PLx Pharma’s Chapter 11 cases were closed on March 11, 2024, following an asset sale and confirmation of a liquidation plan. The final decree Dkt. 370 terminated claims and noticing services subject to the agent’s remaining obligations and required the debtors to submit any remaining quarterly reports and pay outstanding U.S. Trustee fees within 30 days of entry.

PLx Pharma’s Chapter 11 cases were closed on March 11, 2024, following an asset sale and confirmation of a liquidation plan. The final decree Dkt. 370 terminated claims and noticing services subject to the agent’s remaining obligations and required the debtors to submit any remaining quarterly reports and pay outstanding U.S. Trustee fees within 30 days of entry.